Association Between New 340B Program Participation and Commercial Insurance Spending on Outpatient Biologic Oncology Drugs

IMPORTANCE: Previous studies have found that hospitals participating in the 340B Drug Pricing Program have higher Medicare Part B spending and expansion into affluent neighborhoods. Less is known about the association of 340B participation with spending by commercial insurance, where reimbursements...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Jessica, Karaca-Mandic, Pinar, Nikpay, Sayeh, Jeffery, Molly Moore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290244/
https://www.ncbi.nlm.nih.gov/pubmed/37351874
http://dx.doi.org/10.1001/jamahealthforum.2023.1485

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290244/
https://www.ncbi.nlm.nih.gov/pubmed/37351874
http://dx.doi.org/10.1001/jamahealthforum.2023.1485

Ejemplares similares